Unloxcyt Ka 50% Response Rate: Skin Cancer Trial Mein Dhamaka

Sun Pharma ka Unloxcyt trial ka naya data aaya hai, aur kya dhamaka hai! 64 patients par kiye gaye is trial mein, 50% ne response diya, jisme 27% ko complete response mila. Safety profile bhi theek hai, sirf thodi anaemia aur diarrhoea ki baatein hain. Yeh data ASCO Annual Meeting mein 31 May ko present hoga, toh sab log tayaar raho!